These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31114334)

  • 1. Wnt5a induces ROR1 and ROR2 to activate RhoA in esophageal squamous cell carcinoma cells.
    Wu X; Yan T; Hao L; Zhu Y
    Cancer Manag Res; 2019; 11():2803-2815. PubMed ID: 31114334
    [No Abstract]   [Full Text] [Related]  

  • 2. Wnt5a/ROR1 activates DAAM1 and promotes the migration in osteosarcoma cells.
    Dai B; Shen Y; Yan T; Zhang A
    Oncol Rep; 2020 Feb; 43(2):601-608. PubMed ID: 31894282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daam1 activates RhoA to regulate Wnt5a‑induced glioblastoma cell invasion.
    Liu G; Yan T; Li X; Sun J; Zhang B; Wang H; Zhu Y
    Oncol Rep; 2018 Feb; 39(2):465-472. PubMed ID: 29207169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt5a induces ROR1/ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation.
    Yu J; Chen L; Cui B; Widhopf GF; Shen Z; Wu R; Zhang L; Zhang S; Briggs SP; Kipps TJ
    J Clin Invest; 2016 Feb; 126(2):585-98. PubMed ID: 26690702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the Ror family receptors in Wnt5a signaling.
    Kamizaki K; Minami Y; Nishita M
    In Vitro Cell Dev Biol Anim; 2024 May; 60(5):489-501. PubMed ID: 38587578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ror family receptor tyrosine kinases regulate the maintenance of neural progenitor cells in the developing neocortex.
    Endo M; Doi R; Nishita M; Minami Y
    J Cell Sci; 2012 Apr; 125(Pt 8):2017-29. PubMed ID: 22328498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dvl2-dependent activation of Daam1 and RhoA regulates Wnt5a-induced breast cancer cell migration.
    Zhu Y; Tian Y; Du J; Hu Z; Yang L; Liu J; Gu L
    PLoS One; 2012; 7(5):e37823. PubMed ID: 22655072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ROR2 receptor promotes the migration of osteosarcoma cells in response to Wnt5a.
    Dai B; Yan T; Zhang A
    Cancer Cell Int; 2017; 17():112. PubMed ID: 29213214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essential role of Wnt5a-Ror1/Ror2 signaling in metanephric mesenchyme and ureteric bud formation.
    Qi X; Okinaka Y; Nishita M; Minami Y
    Genes Cells; 2016 Apr; 21(4):325-34. PubMed ID: 26840931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insight into the role of Wnt5a-induced signaling in normal and cancer cells.
    Endo M; Nishita M; Fujii M; Minami Y
    Int Rev Cell Mol Biol; 2015; 314():117-48. PubMed ID: 25619716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion.
    Henry C; Llamosas E; Knipprath-Meszaros A; Schoetzau A; Obermann E; Fuenfschilling M; Caduff R; Fink D; Hacker N; Ward R; Heinzelmann-Schwarz V; Ford C
    Oncotarget; 2015 Nov; 6(37):40310-26. PubMed ID: 26515598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wnt5a induces ROR1 to complex with HS1 to enhance migration of chronic lymphocytic leukemia cells.
    Hasan MK; Yu J; Chen L; Cui B; Widhopf Ii GF; Rassenti L; Shen Z; Briggs SP; Kipps TJ
    Leukemia; 2017 Dec; 31(12):2615-2622. PubMed ID: 28465529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt5a and ROR1 activate non-canonical Wnt signaling via RhoA in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targeting.
    Karvonen H; Perttilä R; Niininen W; Hautanen V; Barker H; Murumägi A; Heckman CA; Ungureanu D
    Oncogene; 2019 Apr; 38(17):3288-3300. PubMed ID: 30631148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrin αvβ3-associated DAAM1 is essential for collagen-induced invadopodia extension and cell haptotaxis in breast cancer cells.
    Yan T; Zhang A; Shi F; Chang F; Mei J; Liu Y; Zhu Y
    J Biol Chem; 2018 Jun; 293(26):10172-10185. PubMed ID: 29752407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into the molecular mechanisms of ROR1, ROR2, and PTK7 signaling from the proteomics and pharmacological modulation of ROR1 interactome.
    Raivola J; Dini A; Salokas K; Karvonen H; Niininen W; Piki E; Varjosalo M; Ungureanu D
    Cell Mol Life Sci; 2022 May; 79(5):276. PubMed ID: 35504983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt5a induces ROR1 to associate with 14-3-3ζ for enhanced chemotaxis and proliferation of chronic lymphocytic leukemia cells.
    Yu J; Chen L; Chen Y; Hasan MK; Ghia EM; Zhang L; Wu R; Rassenti LZ; Widhopf GF; Shen Z; Briggs SP; Kipps TJ
    Leukemia; 2017 Dec; 31(12):2608-2614. PubMed ID: 28465528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ROR1 and ROR2 play distinct and opposing roles in endometrial cancer.
    Henry CE; Llamosas E; Daniels B; Coopes A; Tang K; Ford CE
    Gynecol Oncol; 2018 Mar; 148(3):576-584. PubMed ID: 29395309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Ror-Family Receptors in Development, Tissue Regeneration and Age-Related Disease.
    Endo M; Kamizaki K; Minami Y
    Front Cell Dev Biol; 2022; 10():891763. PubMed ID: 35493090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and impact of non-canonical WNT signaling on outcomes of urothelial carcinoma.
    Meagher M; Krause H; Elliott A; Farrell A; Antonarakis ES; Bastos B; Heath EI; Jamieson C; Stewart TF; Bagrodia A; Nabhan C; Oberley M; McKay RR; Salmasi A
    Cancer Med; 2024 Apr; 13(7):e7148. PubMed ID: 38558536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of WNT5A/ROR2 Signaling Characterizes the Progression of Barrett-Associated Esophageal Adenocarcinoma.
    Lyros O; Nie L; Moore T; Medda R; Otterson M; Behmaram B; Mackinnon A; Gockel I; Shaker R; Rafiee P
    Mol Cancer Res; 2016 Jul; 14(7):647-59. PubMed ID: 27084312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.